¤³¤Î¥Ú¡¼¥¸¡ÊTADACIP-20 ¶øÅþ¡ÖËÖµ¯»ýåô²áµ×¡ÊPriapism¡Ë¡××ãÖ÷ÑÝÍý¡©¡ËÆâ¤Î¥¹¥­¥Ã¥×¥á¥Ë¥å¡¼
  1. ¥µ¥¤¥È¤Î¥á¥¤¥ó¥á¥Ë¥å¡¼¤Ø°Üư
  2. ¥µ¥¤¥È¤Î¥æ¡¼¥¶¥á¥Ë¥å¡¼¤Ø°Üư
  3. ¤³¤Î¥Ú¡¼¥¸¡ÊTADACIP-20 ¶øÅþ¡ÖËÖµ¯»ýåô²áµ×¡ÊPriapism¡Ë¡××ãÖ÷ÑÝÍý¡©¡Ë¤Î¥á¥¤¥ó¥³¥ó¥Æ¥ó¥Ä¤Ø°Üư

°Ê²¼¡¢¤³¤Î¥Ú¡¼¥¸(TADACIP-20 ¶øÅþ¡ÖËÖµ¯»ýåô²áµ×¡ÊPriapism¡Ë¡××ãÖ÷ÑÝÍý¡©)¤Î¥á¥¤¥ó¥³¥ó¥Æ¥ó¥Ä¤Ç¤¹¡£

¥³¥ß¥å¥Ë¥Æ¥£¡§
TADACIP-20 ¶øÅþ¡ÖËÖµ¯»ýåô²áµ×¡ÊPriapism¡Ë¡××ãÖ÷ÑÝÍý¡©¡Ê¤´¶á½ê¤Î³¹¥Í¥¿¡Ë

TADACIP-20 ¶øÅþ¡ÖËÖµ¯»ýåô²áµ×¡ÊPriapism¡Ë¡××ãÖ÷ÑÝÍý¡©
¥²¥¹¥È TADACIP-20 ¶øÅþ¡ÖËÖµ¯»ýåô²áµ×¡ÊPriapism¡Ë¡××ãÖ÷ÑÝÍý¡©
ºßÃËÀ­½õËÖé»»Ô¾ìÃæ¡¤°õÅÙºÔÍø»Î TADACIP-20¡Ê¾ãÙÇÈó Tadalafil 20mg¡Ë À§Í³°õÅÙÀ½é»µðƬ Cipla Ltd. ½ÐÉÊŪ¹âÉʼÁÕÜ̾黡£Çç´¾ TADACIP-20 °õÅÙºÔÍø»ÎÕÜÌ¾é» °ÊãÓÄêé»Úᢲ÷®µ¯ÚÃçвĻýåô 36 ¾®»þŪ¡ÖĹÚýõËÖÎÏ¡×ʹ̾¡¤À®°Ùµö¿ÃËÀ­²þÁ±ËÖµ¯¸ùǽ¾ã㨡ÊED¡ËŪ¼óÁª¡£
Á³¼©¡¤ºßÉôʬ¾ð¶·²¼¡¤ÉþÍÑ TADACIP-20 ¸å²Äǽ½Ð¸½æ§¸«Ã¢Óî½ÅŪÉûºîÍÑ——ËÖµ¯»ýåô²áµ×¡ÊPriapism¡Ë¡£ËÜʸÕò·ë¹çîÐÕܸ¦µæÚËÚ¡çÐÎ×¾²å´ñ䡤¾ÜºÙ²òÀÏÇç°ì¸½¾ÝŪ¸¶°ø¡¢´íðªÀ­çÐØæÕôÊý¼°¡¤幫½õ»ÈÍѼ԰ÂÁ´»ÈÍÑ TADACIP-20 ¾ãÙÇÈóÕÜ̾

00000000..png

°ì¡¢½ºÖ÷À§¡ÖËÖµ¯»ýåô²áµ×¡ÊPriapism¡Ë¡×¡©
º¬Ú¡ÈþÔ¢ÈçÇ¢²ÊîÐÕÜÐò¡ÊAUA¡ËŪÄêµÁ¡¤Priapism¡Ê»ýåôÀ­ËÖµ¯¾É¡Ë À§»Ø±¢è³ºß̤¼õÅþÀ­»É·ã²¼Ð»»ýåôËÖµ¯Ä¶²á 4 ¾®»þ°Ê¾å¡¤³î̵ˡ¼«Á³¾ÃÂàŪ¾ð¶·¡£ÇçÀ§ TADACIP-20 ÉûºîÍÑ Ãæ¶Ë¾¯¸«Ã¢¼ûΩ¨ÑÝÍýŪ°ì¼ï狀¶·¡£

Î×¾²¾å²Äʬ°ÙÑÀÎà¡§

åþ·ìÀ­ Priapism¡ÊIschemic¡Ë¡§佔½êÍ­ÉÂÎãÌó 95%¡¤°ÙîÐÎŵ޾ɡ£±¢è³³¤ÌÊñó·ì±ÕÞüα¡¢åþ氧¡¤¼ãͲá 6 ¾®»þÐòƳÃ×ÁÈ¿¥Ôջࡣ

Èóåþ·ìÀ­ Priapism¡ÊNon-ischemic¡Ë¡§ÄÌ¾ï°ø·ì´ÉÁϽý°¿³°ÎÏÆ³Ãס¤ê­ÉÔ´íµÚÀ¸Ì¿¡¤Ã¢Ð»¼ûîлÕÉ¾ÐÆ¡£

º¬Ú¡ Journal of Urology (2018) Ê󯳡¤¼ãËÖµ¯»ýåôͲá 24 ¾®»þ̤¼£ÎÅ¡¤90% °Ê¾å´µ¼ÔÐò½Ð¸½±Êµ×À­ËÖµ¯¸ùǽ¾ã㨡£

Æó¡¢°Ù²¿ÉþÍÑ TADACIP-20 Ðò½Ð¸½ Priapism¡©
TADACIP-20 ŪÀ®Ê¬°Ù ¾ãÙÇÈó¡ÊTadalafil¡Ë¡¤Ö¤±÷ PDE5 ÍÞÀ©Ñý¡ÊPhosphodiesterase type-5 inhibitor¡Ë¡£ÕàǽÊüò¢±¢è³³¤ÌÊñóÊ¿³êÈ©¡¢Â¥¿Ê·ì±ÕήÆþ¡¤Ã£Åþ»ýµ×ËÖµ¯ÅªÚò̡£

âºßË¿º³ÆÃ¼ì狀¶·²¼¡¤é»Úòᶯ°¿Âå¼Õ°Û¾ï²ÄǽƳÃ×·ì±Õ̵ˡÀµ¾ï²óή¡¤·ÁÀ®±¢è³·ìήÞüα¡£

¾ï¸«ÅªÍ¶â¤¸¶°øÊñ³ç¡§

TADACIP-20 ÑýÎ̲á¹â¡ÊͲá每Æü·úµÄ 20mg¡Ë

Ʊ»þ»ÈÍѶ¾½õËÖ黡ÊÇ¡ Super P-Force¡¢Sildenafil¡¢Levitra¡Ë

°û¼ò°¿»ÈÍÑÆÇÉÊ¡ÊÆÃÊÌÀ§²Ä卡°ø¡¢°ÂÈó¾̿¡Ë

´µÍ­·ì±Õ¼ÀÉ¡ÊÇ¡鐮狀ºÙ˦ÉÏ·ì¡¢Çò·ìÉ¡Ë

´Î¿Õ¸ùǽ¼õ»ƳÃ×é»ÊªÂå¼ÕÚÎËý

º¬Ú¡ European Urology (2020) ¸¦µæ¡¤ÉþÍÑ PDE5 ÍÞÀ©Ñý¸å½Ð¸½ Priapism Ūµ¡Î¨¾®±÷ 0.1%¡¤Ã¢¼ã¹çÊ»·ì±Õ¼Àɰ¿ÍôÍÑé»Êª¡¤É÷ðª²Äǽ¾å¾£ 5~10 ÇÜ¡£

23323.png

»°¡¢ËÖµ¯²áµ×Ū´íðªÀ­
¼ã»ÈÍÑ TADACIP-20 °õÅÙºÔÍø»ÎÕÜÌ¾é» ¸å½Ð¸½ËÖµ¯Ä¶²á 4 ¾®»þ̤¾ÃÂࡤ±¢è³內·ì±Õ°øåþ氧Ðò¤À®¡§

·àÎõáÖÄËçмðı

±¢è³ÁÈ¿¥åþ·ìÔÕ»à

±Êµ×À­ËÖµ¯¸ùǽ¾ã㨡ÊED¡Ë

Óî½Å»þ¼û¿Ê¹Ô³°²Ê¼ê½Ñ

American Journal of Emergency Medicine (2021) Êó¹ð»Ø½Ð¡§
¼ãºß 6 ¾®»þ內¼£ÎÅ Priapism¡¤´µ¼Ô´°Á´²úÉüËÖµ¯¸ùÇ½ÅªÈæÎã¹âã 77%¡¨¼ãͲá 24 ¾®»þ̤ÑÝÍý¡¤²úÉüΨ¶ÏÑô 25%¡£

»Í¡¢â¤À¸¡ÖËÖµ¯»ýåô²áµ×¡×»þŪÀµ³ÎÑÝÍýÊý¼°
¼ãÉþÍÑ TADACIP-20 ¾ãÙÇÈóÕÜÌ¾é» ¸å½Ð¸½Ä¹»þ´ÖËÖµ¯¡¤ÀÁΩ¨ºÎ¼è°Ê²¼步ñå¡§

Ää»ß½êÍ­À­»É·ãçб¿Æ°¡¤ÊÝ»ýÎäðС£

»ÈÍÑÑÖÉß±¢è³º¬Éô¡Ê每¼¡ 10~15 ʬ¾â¡Ë¡¤Í­½õ·ì´ÉÚÀ½Ì¡£

ÈòÌȼ«¹ÔÉþÍÑ»ßÄËé»°¿¹ßÔÚ黡¤°ÊÌȱ泸ɾð¡£

¼ãËÖµ¯»ýåôͲá 4 ¾®»þ¡¤ØæÎ©Â¨½¢îС£

ºßîб¡¡¤ÈçÇ¢²ÊîлղÄǽºÎÍѰʲ¼¼£ÎÅÊý¼°¡§

±¢è³Ãê·ì¸ºÔÚ¡ÊAspiration therapy¡Ë¡§Ãê½ÐÞüα·ì±Õ°Ê¹ßÄãÔÚÎÏ¡£

¶ÉÉôÃí¼Íµî氧¿Õ¾åÁ£ÁÇ¡ÊPhenylephrine¡Ë¡§Â¥¿Ê·ì´ÉÚÀ½Ì¡£

¼ê½Ñ°úή¡ÊShunt operation¡Ë¡§¿ËÕôÓî½Å°¿È¿Ê¤À­ÉÂÎã¡£

.0.0..png

¸Þ¡¢Ç¡²¿ÍÂËÉ TADACIP-20 °ú⤠Priapism
°ÙÈòÌȺ¡ÎàÉûºîÍѺƼ¡â¤À¸¡¤·úµÄ»ÈÍѼԽå¼é°Ê²¼¸¶Â§¡§

Óî³Ê½å¼é TADACIP-20 ÑýÎÌ¡§每Æü¸ÂÉþ°ì¼¡¡£

ÈòÌÈçж¾½õËÖé»Êª°¿¼òÀºÊ»ÍÑ¡£

¼ó¼¡»ÈÍѲÄÀè×Ï TADACIP-10mg ³«»Ïë·»¡È¿Øæ¡£

´µÍ­ËýÀ­¼ÀɼԡÊÇ¡ÅüǢɡ¢¹â·ìÔڡ˼û»öÀè»ðëÎîлա£

ÊÝ»ýÎɹ¥À¸³è½¬´·¡§µ¬Î§±¿Æ°¡¢ÈòÌÈßòÌëçеÛ菸¡£

º¬Ú¡ Cipla À½é»Î×¾²»ñÎÁ¡Ê2022¡Ë¡¤ºß½å¼éîлջؼ¨ÉþÍÑŪ²·²Ã桤â¤À¸ËÖµ¯²áµ×°¿Óî½ÅÉûºîÍÑÅªÈæÎãÄã±÷ 0.05%¡£

62323.png

Ï»¡¢åÁ·ë¡§°ÂÁ´»ÈÍÑ TADACIP-20¡¤³ÎÊÝÀ­·ò¹¯
TADACIP-20¡Ê¾ãÙÇÈó 20mg¡Ë À§°ì´¾¹âÚᢻýµ×³î°ÂÁ´À­¹âŪ °õÅÙºÔÍø»ÎÕÜ̾黡¤Ã¢¼ã»ÈÍÑÉÔáÄл²ÄǽƳÃ× Priapism¡ÊËÖµ¯»ýåô²áµ×¡Ë¡£
áĽи½Ä¶²á 4 ¾®»þÉÔÂàŪËÖµ¯»þ¡¤Ì³É¬»ë°ÙîÐÎŵ޾ɡ¤â¸²÷¿ÒµáÈçÇ¢²Ê¶¨½õ¡£
Àµ³ÎÑýÎ̹µÀ©¡¢îÐ»Õ»ØÆ³çаÂÁ´°Õ¼±¡¤À§³ÎÊÝ TADACIP-20 ½õËÖé» â¤´øºÇ²ÂÚòÌŪï𸰡£

Áêïð產ÉÊ¿äÁ¦¡§¶âïÓ͵éçèÎÏãÒÖÚÃÊÒ ùþÔ¢¹ÈËâ°Ò³ÊÙÇ¡ÊVIGORA ¡Ë¿å²ÌÌ£¸ýÍϾû°Ò 100mg ÀµÉʹá¹ÁÏ·ÃæîÐ °õÅÙ½ã¿Ê¸ýÀµÉÊÉ¬ÍøÒ¦Priligy(POXET-60)GOODMAN±¢è³ùáÂç´ÝgoodmanÈþÔ¢ºÔÍø»ÎCialis¸¶êæ¿Ê¸ý®ÚýõËÖ

±ä¿­閱즡§Tadacip-20 »ÈÍÑçп´·ì´Éé»Êª¸ò¸ßºîÍÑ
 

¤³¤Î¥¹¥ì¥Ã¥É¡ÊTADACIP-20 ¶øÅþ¡ÖËÖµ¯»ýåô²áµ×¡ÊPriapism¡Ë¡××ãÖ÷ÑÝÍý¡©¡Ë¤ËÅê¹Æ

[Åê¹Æµ­»ö¤Îºï½ü¥¬¥¤¥É¥é¥¤¥ó¤Ï¤³¤Á¤é¡ÊPDF¡Ë]

Âê̾
¥²¥¹¥È̾
Åê¹ÆËÜʸ
²èÁü¤ÎÅê¹Æ


°Ê²¼¡¢¤³¤Î¥µ¥¤¥È(¤ß¤ó¤Ê¤ÎÁ¥¶¶)¤Î¥æ¡¼¥¶ÍÑ¥á¥Ë¥å¡¼¤È¡¢ÅÐÏ¿¤µ¤ì¤¿Á¥¶¶ Çð »ÔÀî ½¬»ÖÌî ȬÀéÂå ¤Î´ë¶È¤ªÅ¹¾ðÊó¤Î¥«¥Æ¥´¥ê°ìÍ÷¤Ç¤¹¡£
¤³¤Î¥Ú¡¼¥¸¤ÎÀèÆ¬¤ØÌá¤ë

¤³¤ó¤Ð¤ó¤Ï¡ª
¥²¥¹¥È¤µ¤ó

¥²¥¹¥È¤µ¤ó